AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36134902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 36134902 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 30
Study 34322673 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 550 mg BID for 10 days
Number of subjects: 38
Study 34322673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 34903538 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine oral rinses (0.12%)
Number of subjects: 40
Study 34903538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36113538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S vaccine (primary dose plus booster dose at 2 months)
Number of subjects: 31300
Study 36113538 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections (two injections 2 months apart)
Number of subjects: 31300
Study 36113538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S vaccine (primary and booster doses)
Number of subjects: 31300
Study 36113538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S vaccine (booster dose)
Number of subjects: 31300
Study 33932790 — intervention group
Group type: EXPERIMENTAL
Intervention: High diet quality (measured by Australian Recommended Food Score)
Number of subjects: 392
Study 33932790 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable sub-score of diet quality
Number of subjects: 392
Study 36150646 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide Area Transepithelial Sampling (WATS)
Number of subjects: 172
Study 36150646 — intervention group
Group type: COMPARATOR
Intervention: Forceps Biopsy (FB)
Number of subjects: 172
Study 36150646 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of WATS and FB
Number of subjects: 172
Study 36150646 — intervention group
Group type: EXPERIMENTAL
Intervention: WATS
Number of subjects: 172
Study 36150646 — intervention group
Group type: COMPARATOR
Intervention: FB
Number of subjects: 172
Study 33124717 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban demand for wild meat consumption
Number of subjects: 4132
Study 33124717 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of rural‐to‐urban migration
Number of subjects: 4132
Study 33124717 — intervention group
Group type: EXPERIMENTAL
Intervention: Size of urban area
Number of subjects: 4132
Study 33124717 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group comparison
Number of subjects: 4132
Study 33124717 — intervention group
Group type: EXPERIMENTAL
Intervention: Generational change
Number of subjects: 4132
Study 33124717 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservation actions
Number of subjects: 4132
Study 34986166 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-delivered individualised medication review
Number of subjects: 404
Study 34986166 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 404
Study 35994192 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions aimed at reducing disparities in social and behavioral outcomes
Number of subjects: 90880
Study 32847705 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions (6 sessions: 2 educational and 4 motivational)
Number of subjects: 120
Study 32847705 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MI intervention)
Number of subjects: 120
Study 34100234 — intervention group
Group type: EXPERIMENTAL
Intervention: ElderTree (eHealth intervention)
Number of subjects: 390
Study 34100234 — intervention group
Group type: COMPARATOR
Intervention: Control (no access to ElderTree)
Number of subjects: 390
Study 32151464 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access
Number of subjects: 934
Study 32151464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 934
Study 32151464 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access
Number of subjects: 934
Study 32151464 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 934
Study 36170654 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast
Number of subjects: 38
Study 36170654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33468129 — intervention group
Group type: EXPERIMENTAL
Intervention: GI boards (quality oriented and socially integrated)
Number of subjects: 109
Study 33468129 — intervention group
Group type: COMPARATOR
Intervention: non-GI boards (lacking quality orientation and social integration)
Number of subjects: 109
Study 32426471 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-belonging intervention delivered in the first year of college (1-hour exercise)
Number of subjects: 0
Study 32426471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 33629468 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with acne vulgaris
Number of subjects: 90
Study 32186216 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA
Number of subjects: 35
Study 32186216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 36167367 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 126
Study 36167367 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 126
Study 36167367 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of intravenous iron and tranexamic acid
Number of subjects: 126
Study 36167367 — intervention group
Group type: COMPARATOR
Intervention: Control group without treatment
Number of subjects: 126
Study 34106652 — intervention group
Group type: EXPERIMENTAL
Intervention: TSLCB (experimental group)
Number of subjects: 60
Study 34106652 — intervention group
Group type: COMPARATOR
Intervention: Visual estimation and traditional plastic blood‐collecting consumables (control group)
Number of subjects: 60
Study 32609576 — intervention group
Group type: COMPARATOR
Intervention: Conventional frenectomy operation (C group)
Number of subjects: 48
Study 32609576 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser‐assisted frenectomy (L group)
Number of subjects: 48
Study 32609576 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser‐assisted frenectomy with conventional horizontal incision on the periosteum (L + P group)
Number of subjects: 48
Study 32609576 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (C, L, L + P)
Number of subjects: 48
Study 35051233 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (INT)
Number of subjects: 24
Study 35051233 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 24
Study 33507774 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCESS (cognitive-behavioral therapy program)
Number of subjects: 250
Study 32408116 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual minority males
Number of subjects: 535
Study 32408116 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual minority females
Number of subjects: 535
Study 32408116 — intervention group
Group type: COMPARATOR
Intervention: Heterosexual males
Number of subjects: 535
Study 32408116 — intervention group
Group type: COMPARATOR
Intervention: Heterosexual females
Number of subjects: 535
Study 35750379 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintegration into normal life care plan
Number of subjects: 0
Study 35750379 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34728723 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich algae oil supplementation
Number of subjects: 0
Study 32562710 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-stimulus randomisation (IR) protocol
Number of subjects: 11
Study 32562710 — intervention group
Group type: COMPARATOR
Intervention: Increasing blocks (IB) protocol
Number of subjects: 11
Study 32562710 — intervention group
Group type: COMPARATOR
Intervention: Randomised blocks (RB) protocol
Number of subjects: 11
Study 33446402 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversion prevention strategies
Number of subjects: 76
Study 33446402 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge/skill of PCPs
Number of subjects: 76
Study 33446402 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes about the effectiveness of diversion prevention
Number of subjects: 76
Study 33446402 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation climate
Number of subjects: 76
Study 33446402 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource constraints
Number of subjects: 76
Study 33650799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive follow-up group
Number of subjects: 196
Study 33650799 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 196
Study 32726556 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple punctures injection technique of incobotulinumtoxin A (IncoA; Xeomin)
Number of subjects: 24
Study 32726556 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial injection technique of incobotulinumtoxin A (IncoA; Xeomin)
Number of subjects: 24
Study 32726556 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques of incobotulinumtoxin A (IncoA; Xeomin)
Number of subjects: 24
Study 35470152 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Social Skills Training (CBSST) adapted for CHR youth
Number of subjects: 0
Study 35470152 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Social Skills Training (CBSST)
Number of subjects: 0
Study 34164664 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 patients with PE
Number of subjects: 368
Study 34164664 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 patients without PE
Number of subjects: 368
Study 34164664 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 patients with PE ruled out by scanner
Number of subjects: 368
Study 34164664 — intervention group
Group type: COMPARATOR
Intervention: Non-COVID-19 patients with PE
Number of subjects: 368
Study 34164664 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 population
Number of subjects: 368
Study 32657909 — intervention group
Group type: EXPERIMENTAL
Intervention: r-ATG/EVR
Number of subjects: 274
Study 32657909 — intervention group
Group type: EXPERIMENTAL
Intervention: BAS/EVR
Number of subjects: 274
Study 32657909 — intervention group
Group type: COMPARATOR
Intervention: BAS/MPS
Number of subjects: 274
Study 35343353 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (900 lx)
Number of subjects: 0
Study 35343353 — intervention group
Group type: COMPARATOR
Intervention: Standard light (90 lx)
Number of subjects: 0
Study 34259459 — intervention group
Group type: EXPERIMENTAL
Intervention: High-performing resident
Number of subjects: 43
Study 34259459 — intervention group
Group type: EXPERIMENTAL
Intervention: Average-performing resident
Number of subjects: 43
Study 34259459 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-performing resident
Number of subjects: 43
Study 32053478 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fitness tests (sit-and-reach, grip strength, sit-ups, one-leg standing, reaction time, leg extension power)
Number of subjects: 2267
Study 33882760 — intervention group
Group type: EXPERIMENTAL
Intervention: Value-affirmation condition
Number of subjects: 220
Study 33882760 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 220
Study 32277357 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow gastrojejunostomy (30 mm)
Number of subjects: 83
Study 32277357 — intervention group
Group type: COMPARATOR
Intervention: Wide gastrojejunostomy (45 mm)
Number of subjects: 83
Study 35454318 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated injection of 2 mL of 1% lidocaine (three injections; one injection per week)
Number of subjects: 60
Study 35454318 — intervention group
Group type: COMPARATOR
Intervention: Radial extracorporeal shock wave therapy (rESWT) (three treatment sessions; one treatment session per week; 2000 radial extracorporeal shock waves per treatment session; positive energy flux density = 0.10 mJ/mm2)
Number of subjects: 60
Study 33184650 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-sodium oxybate (LXB)
Number of subjects: 201
Study 33184650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 32997386 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed following RTI-related GP consultation
Number of subjects: 992
Study 32997386 — intervention group
Group type: COMPARATOR
Intervention: Control group (children without DS)
Number of subjects: 992
Study 34107786 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary headless cannulated screws (IHCS)
Number of subjects: 69
Study 34107786 — intervention group
Group type: COMPARATOR
Intervention: Locked miniplates
Number of subjects: 69
Study 36490292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) intervention, average of 12 sessions
Number of subjects: 6
Study 36490292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) intervention
Number of subjects: 6
Study 34645660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen alone
Number of subjects: 120
Study 34645660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen and short intervention
Number of subjects: 120
Study 34645660 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamizole alone
Number of subjects: 120
Study 34645660 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamizole and short intervention
Number of subjects: 120
Study 34645660 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 120
Study 34645660 — intervention group
Group type: EXPERIMENTAL
Intervention: Short educational intervention
Number of subjects: 120
Study 36096282 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐DSMES
Number of subjects: 0
Study 36096282 — intervention group
Group type: COMPARATOR
Intervention: Standard‐DSMES
Number of subjects: 0
Study 33517541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab combined with cisplatin
Number of subjects: 104
Study 33517541 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 104
Study 32616271 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% functional oils
Number of subjects: 585
Study 32616271 — intervention group
Group type: EXPERIMENTAL
Intervention: 66-ppm monensin
Number of subjects: 585
Study 32616271 — intervention group
Group type: COMPARATOR
Intervention: Control (nonmedicated)
Number of subjects: 585
Study 32616271 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ppm of virginiamycin
Number of subjects: 585
Study 32616271 — intervention group
Group type: COMPARATOR
Intervention: Control (no additive)
Number of subjects: 585
Study 35916290 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300mg with loading dose
Number of subjects: 389
Study 35916290 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150mg with loading dose
Number of subjects: 389
Study 35916290 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150mg without loading dose
Number of subjects: 389
Study 35916290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 33478593 — intervention group
Group type: EXPERIMENTAL
Intervention: EMOTION intervention (10-week CBT-based transdiagnostic intervention)
Number of subjects: 795
Study 33478593 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 795
Study 32465000 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat (up to 2.5 mg tid)
Number of subjects: 340
Study 32465000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 32465000 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat and Placebo (combined analysis)
Number of subjects: 340
Study 35430027 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal psychodynamic therapy
Number of subjects: 0
Study 35430027 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy
Number of subjects: 0
Study 35430027 — intervention group
Group type: COMPARATOR
Intervention: Optimised treatment as usual
Number of subjects: 0
Study 33246481 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia frameworks with ceramic veneering
Number of subjects: 44
Study 33246481 — intervention group
Group type: COMPARATOR
Intervention: Titanium frameworks with acrylic resin veneering
Number of subjects: 44
Study 33463367 — intervention group
Group type: EXPERIMENTAL
Intervention: Active participation in Cantonese opera (ACO)
Number of subjects: 95
Study 33463367 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive participation in Cantonese opera (PCO)
Number of subjects: 95
Study 33463367 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 95
Study 33463367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantonese opera intervention (ACO and PCO combined)
Number of subjects: 95
Study 33615843 — intervention group
Group type: EXPERIMENTAL
Intervention: Unblinded nitroglycerin infusion at 0.5 µg/kg/min for 20 minutes
Number of subjects: 33
Study 33615843 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-blinded nitroglycerin infusion
Number of subjects: 33
Study 33615843 — intervention group
Group type: COMPARATOR
Intervention: Single-blinded placebo infusion
Number of subjects: 33
Study 33615843 — intervention group
Group type: EXPERIMENTAL
Intervention: Unblinded nitroglycerin infusion
Number of subjects: 33
Study 35687936 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cannabis intervention
Number of subjects: 0
Study 35687936 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34624104 — intervention group
Group type: EXPERIMENTAL
Intervention: Remaining Dentin Ferrule (RDF) with mechanical fatigue (F)
Number of subjects: 32
Study 34624104 — intervention group
Group type: EXPERIMENTAL
Intervention: Without Dentin Ferrule (WDF) with mechanical fatigue (F)
Number of subjects: 32
Study 34624104 — intervention group
Group type: COMPARATOR
Intervention: Remaining Dentin Ferrule (RDF) with control (C)
Number of subjects: 32
Study 34624104 — intervention group
Group type: COMPARATOR
Intervention: Without Dentin Ferrule (WDF) with control (C)
Number of subjects: 32
Study 36470556 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically tailored meals (MTM) plus lifestyle intervention
Number of subjects: 200
Study 36470556 — intervention group
Group type: COMPARATOR
Intervention: Food subsidy ($40/month)
Number of subjects: 200
Study 33933059 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (360 μg MK-7 daily for 12 weeks)
Number of subjects: 68
Study 33933059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 32118347 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-managed (nurse-assisted) titration of Gla-300
Number of subjects: 355
Study 32118347 — intervention group
Group type: COMPARATOR
Intervention: Physician-managed titration of Gla-300
Number of subjects: 355
Study 35193044 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially-evaluated cold pressor test (seCPT, n = 29)
Number of subjects: 63
Study 35193044 — intervention group
Group type: COMPARATOR
Intervention: Control condition (warm water, n = 34)
Number of subjects: 63
Study 33236518 — intervention group
Group type: EXPERIMENTAL
Intervention: SARAsp‐Mix
Number of subjects: 52
Study 33236518 — intervention group
Group type: COMPARATOR
Intervention: NN‐Mix‐US
Number of subjects: 52
Study 33236518 — intervention group
Group type: COMPARATOR
Intervention: NN‐Mix‐EU
Number of subjects: 52
Study 33236518 — intervention group
Group type: COMPARATOR
Intervention: SAR‐Asp
Number of subjects: 52
Study 35156756 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Learning module (30-minute duration)
Number of subjects: 177
Study 35156756 — intervention group
Group type: COMPARATOR
Intervention: Control group (test-retest approach)
Number of subjects: 177
Study 34420049 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersible paediatric fixed dose combination (FDC) tablets delivering higher doses of first‐line antituberculosis drugs (rifampicin/isoniazid/pyrazinamide 75/50/150 mg, with or without 100 mg ethambutol, or rifampicin/isoniazid 75/50 mg)
Number of subjects: 77
Study 34420049 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended weight-band based FDC doses
Number of subjects: 77
Study 34420049 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethambutol at current WHO-recommended doses
Number of subjects: 77
Study 35076697 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded continuous glucose monitoring (CGM) for a minimum of 6.5 days (average 11.9 days)
Number of subjects: 765
Study 35076697 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of insulin pumps and CGM
Number of subjects: 765
Study 35076697 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine CGM and insulin pumps
Number of subjects: 765
Study 32900915 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional labor and mental health questionnaire
Number of subjects: 352
Study 32900915 — intervention group
Group type: EXPERIMENTAL
Intervention: App designed to evaluate mental health status
Number of subjects: 352
Study 35706121 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy
Number of subjects: 72
Study 35706121 — intervention group
Group type: EXPERIMENTAL
Intervention: Local corticosteroid injection
Number of subjects: 72
Study 35706121 — intervention group
Group type: COMPARATOR
Intervention: Resting hand splint (Control)
Number of subjects: 72
Study 32604224 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinmailong injection (XMLI)
Number of subjects: 192
Study 32604224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 32993367 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive transition experience
Number of subjects: 217
Study 32993367 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower role stress
Number of subjects: 217
Study 32993367 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothesized model
Number of subjects: 217
Study 32993367 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised model
Number of subjects: 217
Study 32993367 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 217
Study 32798785 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion spectrum imaging−based fiber tracking
Number of subjects: 10